<![CDATA[EU/3/15/1580 (N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4 methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide)

<![CDATA[EU/3/15/1580 (N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4 methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide) - Pharma Gateway AB]]> 1440 Copyright: (C) European Commission en-gb Tue, 13 Jun 2017 12:06:00 +0000 http://ec.europa.eu/health/documents/community-register/html/o1580.htm <![CDATA[EU/3/15/1580 (N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4 methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide) - Pharma Gateway AB]]> http://ec.europa.eu/health/documents/community-register/images/logo_en.gif http://ec.europa.eu/health/documents/community-register/html/o1580.htm 144 100 Change of name and/or address of sponsor - No Commission Decision No new document http://ec.europa.eu/health/documents/community-register/html/o1580.htm#proc138317 http://ec.europa.eu/health/documents/community-register/html/o1580.htm#proc138317 Tue, 13 Jun 2017 12:06:00 +0000 Orphan designation - Commission Decision (2015)8030 of Fri, 13 Nov 2015 New documents http://ec.europa.eu/health/documents/community-register/html/o1580.htm#proc133391 http://ec.europa.eu/health/documents/community-register/html/o1580.htm#proc133391 Fri, 13 Nov 2015 12:11:00 +0000